| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
70,729 |
60,153 |
$2.79M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,534 |
13,061 |
$1.82M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,285 |
24,170 |
$1.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,045 |
12,996 |
$1.21M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,278 |
16,813 |
$1.11M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12,387 |
9,215 |
$876K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,298 |
2,586 |
$577K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,124 |
8,758 |
$278K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,491 |
3,342 |
$228K |
| 11721 |
|
10,679 |
8,531 |
$181K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,920 |
2,513 |
$172K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,031 |
8,332 |
$142K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,197 |
2,027 |
$132K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,739 |
978 |
$129K |
| 36415 |
Collection of venous blood by venipuncture |
40,528 |
34,158 |
$128K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,070 |
1,883 |
$123K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,263 |
1,964 |
$121K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,256 |
2,701 |
$116K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,832 |
4,493 |
$114K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,110 |
1,088 |
$96K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,891 |
2,586 |
$94K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,256 |
1,026 |
$91K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,035 |
1,022 |
$86K |
| 99215 |
Prolong outpt/office vis |
745 |
667 |
$82K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
610 |
561 |
$75K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,969 |
1,465 |
$74K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
877 |
824 |
$62K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,076 |
597 |
$58K |
| 92588 |
|
5,592 |
5,082 |
$56K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,215 |
4,774 |
$47K |
| 92015 |
Determination of refractive state |
3,669 |
3,572 |
$44K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,052 |
8,160 |
$42K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,450 |
2,249 |
$40K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
704 |
668 |
$36K |
| 96127 |
|
7,978 |
6,705 |
$35K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,014 |
345 |
$30K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
607 |
531 |
$27K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
282 |
274 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,816 |
9,643 |
$25K |
| 80053 |
Comprehensive metabolic panel |
5,797 |
5,298 |
$24K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
155 |
141 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,511 |
1,372 |
$24K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
453 |
416 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
687 |
609 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
2,621 |
2,324 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,017 |
962 |
$17K |
| 81514 |
|
123 |
115 |
$17K |
| 80061 |
Lipid panel |
1,667 |
1,609 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
691 |
674 |
$15K |
| 83021 |
|
1,399 |
1,357 |
$14K |
| 0002A |
|
673 |
657 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,915 |
2,683 |
$13K |
| 99188 |
|
997 |
950 |
$13K |
| 0001A |
|
701 |
682 |
$13K |
| 91320 |
|
179 |
171 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
500 |
385 |
$11K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
82 |
62 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
235 |
218 |
$10K |
| 99348 |
|
165 |
154 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
796 |
675 |
$9K |
| 99349 |
|
94 |
93 |
$9K |
| 90480 |
|
362 |
338 |
$9K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
503 |
495 |
$8K |
| 99173 |
|
4,651 |
4,213 |
$8K |
| 86769 |
|
355 |
341 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$7K |
| 90837 |
Psychotherapy, 53 minutes with patient |
142 |
90 |
$7K |
| 90686 |
|
3,184 |
2,993 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
383 |
335 |
$7K |
| 62323 |
|
12 |
12 |
$7K |
| 99307 |
|
389 |
327 |
$6K |
| 99335 |
|
95 |
86 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
268 |
254 |
$6K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
93 |
82 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
268 |
254 |
$5K |
| X5622 |
|
81 |
59 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
331 |
318 |
$5K |
| 0064A |
|
321 |
315 |
$5K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
41 |
28 |
$5K |
| 90677 |
|
55 |
53 |
$5K |
| 99442 |
|
184 |
136 |
$4K |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
194 |
188 |
$4K |
| 97803 |
|
138 |
129 |
$4K |
| 90670 |
|
806 |
724 |
$4K |
| 0004A |
|
186 |
184 |
$4K |
| 0134A |
|
181 |
175 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
84 |
70 |
$4K |
| 82728 |
|
261 |
254 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
27 |
26 |
$3K |
| 90662 |
|
88 |
88 |
$3K |
| 87205 |
|
450 |
420 |
$3K |
| 0072A |
|
109 |
107 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
299 |
286 |
$3K |
| 87808 |
|
302 |
287 |
$2K |
| 99441 |
|
181 |
138 |
$2K |
| 99233 |
Prolong inpt eval add15 m |
133 |
75 |
$2K |
| 85610 |
|
1,170 |
624 |
$2K |
| 0071A |
|
79 |
76 |
$2K |
| 97597 |
|
60 |
41 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
983 |
917 |
$2K |
| 86140 |
|
294 |
275 |
$2K |
| 90682 |
|
69 |
68 |
$2K |
| 0124A |
|
80 |
75 |
$2K |
| 87210 |
|
315 |
302 |
$2K |
| 97161 |
|
33 |
27 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
12 |
$1K |
| 0054A |
|
48 |
46 |
$1K |
| 92557 |
|
42 |
28 |
$1K |
| 85027 |
|
198 |
167 |
$1K |
| 90473 |
|
182 |
165 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
466 |
416 |
$1K |
| 83605 |
|
336 |
310 |
$1K |
| 80076 |
|
299 |
275 |
$881.52 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
45 |
41 |
$855.10 |
| 90656 |
|
246 |
239 |
$841.99 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
25 |
25 |
$839.55 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
75 |
71 |
$779.56 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
337 |
316 |
$766.10 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$689.89 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$685.72 |
| 73030 |
|
30 |
26 |
$670.53 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
37 |
36 |
$668.33 |
| 86592 |
|
72 |
68 |
$594.08 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
12 |
$581.79 |
| 99217 |
|
14 |
13 |
$511.49 |
| J2704 |
Injection, propofol, 10 mg |
770 |
686 |
$509.18 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
27 |
25 |
$439.56 |
| G0124 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
18 |
17 |
$403.03 |
| 99443 |
|
22 |
12 |
$384.96 |
| 88304 |
|
52 |
42 |
$383.86 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
12 |
$332.74 |
| 99490 |
Ccm add 20min |
76 |
75 |
$288.68 |
| 83735 |
|
267 |
242 |
$286.17 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
644 |
553 |
$285.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
368 |
335 |
$284.25 |
| 92567 |
|
49 |
32 |
$283.57 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$279.94 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$273.11 |
| 88142 |
|
38 |
37 |
$242.30 |
| 84145 |
|
35 |
25 |
$240.22 |
| 86780 |
|
13 |
13 |
$183.14 |
| 84484 |
|
62 |
51 |
$179.91 |
| 87631 |
|
12 |
12 |
$157.50 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
103 |
93 |
$143.36 |
| 81000 |
|
133 |
119 |
$121.40 |
| 99406 |
|
14 |
14 |
$116.50 |
| 73630 |
|
51 |
42 |
$109.94 |
| 86703 |
|
13 |
12 |
$107.98 |
| 80305 |
|
12 |
12 |
$101.40 |
| 84703 |
|
16 |
14 |
$98.07 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
47 |
46 |
$95.51 |
| 73564 |
|
38 |
36 |
$89.96 |
| 82077 |
|
15 |
14 |
$87.34 |
| 87653 |
|
13 |
13 |
$86.60 |
| 87899 |
|
13 |
12 |
$82.63 |
| 73610 |
|
30 |
26 |
$71.23 |
| 81001 |
|
41 |
37 |
$62.92 |
| 85730 |
|
54 |
41 |
$59.14 |
| 82043 |
|
12 |
12 |
$54.30 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
49 |
41 |
$49.41 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
13 |
$49.13 |
| 83690 |
|
70 |
63 |
$45.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
474 |
429 |
$44.73 |
| 81025 |
|
14 |
13 |
$44.15 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,890 |
3,594 |
$24.11 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
50 |
40 |
$12.21 |
| J1630 |
Injection, haloperidol, up to 5 mg |
26 |
26 |
$9.26 |
| 90648 |
|
800 |
720 |
$8.99 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
12 |
$5.52 |
| 81002 |
|
13 |
12 |
$3.48 |
| 90723 |
|
191 |
180 |
$0.01 |
| 90680 |
|
161 |
149 |
$0.01 |
| 90633 |
|
176 |
162 |
$0.01 |
| 1111F |
|
1,467 |
1,243 |
$0.00 |
| 1123F |
|
27 |
26 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
58 |
57 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
18 |
12 |
$0.00 |
| 90651 |
|
54 |
53 |
$0.00 |
| 91319 |
|
14 |
12 |
$0.00 |
| 2023F |
|
12 |
12 |
$0.00 |
| 0501F |
|
12 |
12 |
$0.00 |
| 86580 |
|
15 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,201 |
1,046 |
$0.00 |
| 0502F |
|
1,275 |
808 |
$0.00 |
| 1124F |
|
127 |
120 |
$0.00 |
| 90734 |
|
17 |
17 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
68 |
41 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 90685 |
|
14 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
15 |
14 |
$0.00 |